quoted from here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, July 12, 2014
FDA asked the company to recall all non-expired lots of sterile drug products, but the company refused to do so. Today, FDA issued a formal request3 for Unique Pharmaceuticals to recall all non-expired lots of its sterile products currently on the market. FDA has also asked the company to cease sterile compounding operations until sufficient corrections are made at its facility. However, Unique Pharmaceuticals has refused to cease sterile compounding operations.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment